Skip to main navigation
Skip to main content
Skip to Footer
Google Tag Manager
Navigate Novartis
Patients
Healthcare Professionals
Media
Investors
Partners
ESG
Job Seekers
Clinical Trials
Coronavirus
Global
Novartis site directory
Our Company
Our Leadership
Board of Directors
Executive Committee of Novartis
Our Approach
Strategy
Corporate Responsibility
Diversity & Inclusion
Partnering
People and Culture
Our Business
Global Product Portfolio
Innovative Medicines
Novartis Pharmaceuticals
Novartis Gene Therapies
Novartis Oncology
Sandoz
Media
Newsroom
News Archive
Multimedia Resources
Subscribe to Updates
Investors
Event Calendar
Financial Data
Share Data & Analysis
Shareholder Information
Environmental, Social & Governance
Our Focus
Disease Areas
Cancer
Cardiovascular, Renal & Metabolism
Immunology & Dermatology
Ophthalmology
Neuroscience
Respiratory
Platforms and Technology
Data and Digital
Cell & Gene Therapy
Novartis Stories
Discovery
From Our Labs
Access to Healthcare
Patient Perspectives
People and Culture
Live Magazine
Our Impact
Building Trust with Society
Corporate Responsibility
Ethical Standards
Access
Environmental Sustainability
Global Health
Malaria
Sickle Cell Disease
Chagas disease
Leprosy
Novartis Foundation
ESG Performance and Reporting
Materiality
Environment, Social and Governance
Transparency and Disclosures
Positions on Key Topics
Statements on Key Issues
Our Science
Research & Early Development
Novartis Institutes for BioMedical Research
Research Disease Areas
Postdoc Program
Open Source Science
Drug Development at Novartis
Novartis Pipeline
Clinical Trials
Translational Medicine
Global Product Portfolio
Science Stories
Discovery
From Our Labs
Careers
Your Career
Novartis Career Search
Novartis Teams and Skills
Working at Novartis
Diversity & Inclusion
Corporate Responsibility
Career Programs
Our Career Programs
Students and Scholars
Novartis Quantitative Sciences Hackathon
Search
Gene Testing
View All Stories
From Our Labs
Neuroscientists target Alzheimer’s “silent stage”
Patient Perspectives
Lung Cancer: To test or not to test
Patient Perspectives
Your Genes, Your Melanoma
Discovery
Clinical trials make a move toward mice
Discovery
Genetic testing for Alzheimer’s disease risk
From Our Labs
Chemical genetics: The sleuthing behind modern drug discovery
Discovery
Novartis researches SMA’s genetic roots
